These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8013160)

  • 1. Etodolac clinical pharmacokinetics.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy.
    Brocks DR; Jamali F; Russell AS; Skeith KJ
    J Clin Pharmacol; 1992 Nov; 32(11):982-9. PubMed ID: 1474171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of flurbiprofen and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1995 Feb; 28(2):100-14. PubMed ID: 7736686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective disposition of etodolac enantiomers in synovial fluid.
    Brocks DR; Jamali F; Russell AS
    J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.
    Brocks DR; Jamali F
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):293-9. PubMed ID: 1301359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.
    Fleishaker JC
    Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of enterohepatic circulation of etodolac and effect of hepatic and renal injury on the pharmacokinetics.
    Ogiso T; Kitagawa T; Iwaki M; Tanino T
    Biol Pharm Bull; 1997 Apr; 20(4):405-10. PubMed ID: 9145219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers.
    Hewala II; Moneeb MS; Elmongy HA; Wahbi AA
    Talanta; 2014 Dec; 130():506-17. PubMed ID: 25159440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
    Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
    Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Dalla Costa T; Lanchote VL; Schmidt S; Bulitta JB
    AAPS J; 2017 Nov; 19(6):1814-1825. PubMed ID: 28875479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
    Brocks DR; Jamali F
    J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of ketoprofen and its enantiomers.
    Jamali F; Brocks DR
    Clin Pharmacokinet; 1990 Sep; 19(3):197-217. PubMed ID: 2203580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Lanchote VL
    J Pharm Biomed Anal; 2016 Feb; 120():120-6. PubMed ID: 26723001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin binding sites for etodolac enantiomers.
    Mignot I; Presle N; Lapicque F; Monot C; Dropsy R; Netter P
    Chirality; 1996; 8(3):271-80. PubMed ID: 8777148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of dexketoprofen.
    Barbanoj MJ; Antonijoan RM; Gich I
    Clin Pharmacokinet; 2001; 40(4):245-62. PubMed ID: 11368291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
    Jin YX; Tang YH; Zeng S
    J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profile of etodolac in special populations.
    Benet LZ
    Eur J Rheumatol Inflamm; 1994; 14(1):15-8. PubMed ID: 7744123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the stereoselective metabolism of the chiral analgesic drug etodolac by high-performance liquid chromatography.
    Becker-Scharfenkamp U; Blaschke G
    J Chromatogr; 1993 Nov; 621(2):199-207. PubMed ID: 8294542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.